Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Flurbiprofen (0.03% w/v) + Gatifloxacin (0.3% w/v)
Dosage Form : Eye Drops
Packaging Type : Dropper
Packaging : 5ml
Price : ₹125/-
Gatitrip FL Eye Drop is a dual-action formulation combining Flurbiprofen (0.03% w/v), a nonsteroidal anti-inflammatory drug (NSAID), and Gatifloxacin (0.3% w/v), an antibiotic, to provide comprehensive treatment for various eye infections and inflammation.
This eye drop is primarily indicated for the treatment of ocular inflammation associated with post-operative cataract surgery and for preventing and treating eye infections. Flurbiprofen works by reducing inflammation, pain, and swelling, while Gatifloxacin combats bacterial infections by inhibiting bacterial DNA synthesis, effectively treating eye infections caused by susceptible organisms. This combination makes Gatitrip FL Eye Drop an effective choice for patients undergoing eye surgery or experiencing eye infections and inflammation.
It is used under medical supervision to manage the symptoms of ocular conditions and infections. The dual action of both the anti-inflammatory and antibiotic properties provides fast relief and minimizes the risk of complications such as infection after eye surgery.
Temporary burning, stinging, or blurred vision may occur. Rarely, allergic reactions like redness or itching in the eyes can happen.
Treatment of ocular inflammation and bacterial infections following cataract surgery.
Do not use if allergic to any of the ingredients. Consult your doctor before use if pregnant or breastfeeding.
Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.
Composition : Ofloxacin (0.3% w/v) + Ketorolac (0.5% w/v)
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
Composition : Moxifloxacin (0.5% w/v) + Prednisolone (1% w/v)
Composition : Moxifloxacin (0.5% w/v) + Difluprednate (0.05% w/v)
Composition : Moxifloxacin (0.5% w/v) + Dexamethasone (0.1% w/v)
Composition : Moxifloxacin (5% w/v) + Betamethasone (0.1% w/v)
Composition : Ofloxacin (0.3% w/v) Eye Ear Drops
Composition : Tobramycin (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation